Murtaza Kadhum1, Abdel Rahim Elniel2, Dominic Furniss1. 1. Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, Botnar Research Centre, University of Oxford, Oxford, UK. 2. Trauma and Orthopaedics, Leeds Teaching Hospital Trust, Leeds, UK.
Abstract
BACKGROUND: Upper limb arthroplasty is an increasingly used treatment modality for end-stage joint disease of the shoulder, elbow and wrist. Whilst complications have been reported, the risk of venous thromboembolism has received less attention when compared to the lower limb. Guidance to aid clinical decision-making remains limited. This review aims to ascertain whether venous thromboembolism prophylaxis is beneficial after upper limb major joint replacement surgery. METHODS: A systematic review was performed in April 2019, utilising EMBASE, MEDLINE, Cochrane and Google Scholar. All clinical studies reporting venous thromboembolism incidence and risk reduction (after prophylaxis) in upper limb joint replacement were included. RESULTS: Twenty-four observational studies were identified. The reported incidence of venous thromboembolism ranged from 0.2% to 16% (weighted mean 0.68%) and 0.2% to 0.8% (weighted mean 0.49%) in shoulder and elbow arthroplasty, respectively. No records for wrist arthroplasty were found. In the literature, baseline venous thromboembolism risk of patients without an operation is reported as 0.5%. DISCUSSION: There is a lack of good quality evidence regarding the risks and benefits of venous thromboembolism prophylaxis in upper limb major joint replacement surgery. We recommend further research, ideally formal randomised controlled trials to guide recommendations. Although venous thromboembolism is rare in upper limb surgery, surgeons should remain vigilant to this possibility.
BACKGROUND: Upper limb arthroplasty is an increasingly used treatment modality for end-stage joint disease of the shoulder, elbow and wrist. Whilst complications have been reported, the risk of venous thromboembolism has received less attention when compared to the lower limb. Guidance to aid clinical decision-making remains limited. This review aims to ascertain whether venous thromboembolism prophylaxis is beneficial after upper limb major joint replacement surgery. METHODS: A systematic review was performed in April 2019, utilising EMBASE, MEDLINE, Cochrane and Google Scholar. All clinical studies reporting venous thromboembolism incidence and risk reduction (after prophylaxis) in upper limb joint replacement were included. RESULTS: Twenty-four observational studies were identified. The reported incidence of venous thromboembolism ranged from 0.2% to 16% (weighted mean 0.68%) and 0.2% to 0.8% (weighted mean 0.49%) in shoulder and elbow arthroplasty, respectively. No records for wrist arthroplasty were found. In the literature, baseline venous thromboembolism risk of patients without an operation is reported as 0.5%. DISCUSSION: There is a lack of good quality evidence regarding the risks and benefits of venous thromboembolism prophylaxis in upper limb major joint replacement surgery. We recommend further research, ideally formal randomised controlled trials to guide recommendations. Although venous thromboembolism is rare in upper limb surgery, surgeons should remain vigilant to this possibility.
Authors: N van Rein; J S Biedermann; F J M van der Meer; S C Cannegieter; N Wiersma; H W Vermaas; P H Reitsma; M J H A Kruip; W M Lijfering Journal: J Thromb Haemost Date: 2017-05-30 Impact factor: 5.824
Authors: David R Anderson; Michael Dunbar; John Murnaghan; Susan R Kahn; Peter Gross; Michael Forsythe; Stephane Pelet; William Fisher; Etienne Belzile; Sean Dolan; Mark Crowther; Eric Bohm; Steven J MacDonald; Wade Gofton; Paul Kim; David Zukor; Susan Pleasance; Pantelis Andreou; Steve Doucette; Chris Theriault; Abongnwen Abianui; Marc Carrier; Michael J Kovacs; Marc A Rodger; Doug Coyle; Philip S Wells; Pascal-Andre Vendittoli Journal: N Engl J Med Date: 2018-02-22 Impact factor: 91.245
Authors: Christopher Lenarz; Yousef Shishani; Christopher McCrum; Robert J Nowinski; T Bradley Edwards; Reuben Gobezie Journal: Clin Orthop Relat Res Date: 2011-12 Impact factor: 4.176
Authors: Ronald A Navarro; Maria C S Inacio; Mary F Burke; John G Costouros; Edward H Yian Journal: Clin Orthop Relat Res Date: 2013-02-08 Impact factor: 4.176
Authors: Paul J Jenkins; Adam C Watts; Tim Norwood; Andrew D Duckworth; Lech A Rymaszewski; Jane E McEachan Journal: Acta Orthop Date: 2013-03-14 Impact factor: 3.717